From: Breast cancer: the first comparative evaluation of oncobiome composition between males and females
Patient ID | Age | Gender | Diagnosis | Tumor differentiation | Regional lymph nodes | Estrogen receptor (SP1) | Progesterone receptor (1E2) | Ki67 | c-erb-B2 |
---|---|---|---|---|---|---|---|---|---|
BC1 | 70 | F | Invasive lobular carcinoma | G2 | pN0 | 100% | 10% | 15% | Score 1+ |
BC 2 | 64 | F | Invasive lobular carcinoma | G2 | pN3a | 100% | 10% | 15% | Score 1+ |
BC 3 | 33 | F | Invasive NSTNST carcinoma | G3 | pN1a | 100% | 40% | 60% | Score 0 |
BC 4 | 47 | F | Invasive lobular carcinoma | G2 | pN0 | 100% | 90% | 20% | Score 2+ |
BC 5 | 42 | F | Invasive NST carcinoma | G3 | pN0 | 100% | 80% | 80% | Score 1+ |
BC 6 | 46 | F | Invasive NST carcinoma | G2 | pN0 | 100% | 100% | 25% | Score 2+ |
BC 7 | 48 | F | Invasive papillary carcinoma | G3 | pN0 | 100% | 90% | 25% | Score 2+ |
BC 8 | 42 | F | Invasive NST carcinoma | G2 | pN1a | 100% | 100% | 30% | Score 2+ |
BC 9 | 39 | F | Invasive NST carcinoma | G3 | pN0 | Negative | Negative | 80% | Score 0 |
BC 10 | 79 | F | Invasive lobular carcinoma | G2 | pN0 | 100% | 90% | 15% | Score 2+ |
BC11 | 77 | M | Invasive papillary carcinoma | G2 | pN0 | 100% | 90% | 25% | Score 2+ |
BC 12 | 48 | M | Invasive NST carcinoma | G2 | pNx | 100% | 100% | 20% | Score 0 |
BC 13 | 57 | M | Invasive NST carcinoma | G3 | rpN0 | 100% | 100% | 40% | Score 2+ |
BC 14 | 48 | M | Invasive NST carcinoma | G3 | rpN0 | 90% | 80% | 70% | Score 2+ |
BC 15 | 69 | M | Invasive NST carcinoma | G3 | pN0 | 90% | 30% | 40% | Score 2+ |
BC 16 | 68 | M | Invasive NST carcinoma | G3 | pN2a | 100% | 100% | 30% | Score 0 |
BC 17 | 76 | M | Invasive NST carcinoma | G2 | pN0 | 90% | 10% | 15% | Score 0 |
BC 18 | 84 | M | Invasive NST carcinoma | G3 | pN2a | 100% | 90% | 40% | Score 2+ |
BC 19 | 88 | M | Invasive NST carcinoma | G2 | pNx | 100% | 100% | 25% | Score 2+ |
BC 20 | 82 | M | Invasive NST carcinoma | G2 | pN1a | 90% | 60% | 25% | Score 1+ |